[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cardiac Biomarkers Testing Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: C98527CCE50AEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.

This report contains market size and forecasts of Cardiac Biomarkers Testing in Global, including the following market information:

Global Cardiac Biomarkers Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cardiac Biomarkers Testing market was valued at 7339.2 million in 2021 and is projected to reach US$ 11200 million by 2028, at a CAGR of 6.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Myocardial Muscle Creatine Kinase (CK-MB) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cardiac Biomarkers Testing include Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories, Inc., Danaher Corporation, ROCHE, Siemens AG, Thermo Fisher Scientific, Inc. and PerkinElmer Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiac Biomarkers Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cardiac Biomarkers Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cardiac Biomarkers Testing Market Segment Percentages, by Type, 2021 (%)
  • Myocardial Muscle Creatine Kinase (CK-MB)
  • Troponins (T and I)
  • Myoglobin
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP
  • Ischemia-modified Albumin (IMA)
  • Others
Global Cardiac Biomarkers Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cardiac Biomarkers Testing Market Segment Percentages, by Application, 2021 (%)
  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others
Global Cardiac Biomarkers Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cardiac Biomarkers Testing Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cardiac Biomarkers Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cardiac Biomarkers Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BioMerieux
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • ROCHE
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer Inc.
  • Tosoh Corporation
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cardiac Biomarkers Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cardiac Biomarkers Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CARDIAC BIOMARKERS TESTING OVERALL MARKET SIZE

2.1 Global Cardiac Biomarkers Testing Market Size: 2021 VS 2028
2.2 Global Cardiac Biomarkers Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cardiac Biomarkers Testing Players in Global Market
3.2 Top Global Cardiac Biomarkers Testing Companies Ranked by Revenue
3.3 Global Cardiac Biomarkers Testing Revenue by Companies
3.4 Top 3 and Top 5 Cardiac Biomarkers Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cardiac Biomarkers Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cardiac Biomarkers Testing Players in Global Market
  3.6.1 List of Global Tier 1 Cardiac Biomarkers Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cardiac Biomarkers Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cardiac Biomarkers Testing Market Size Markets, 2021 & 2028
  4.1.2 Myocardial Muscle Creatine Kinase (CK-MB)
  4.1.3 Troponins (T and I)
  4.1.4 Myoglobin
  4.1.5 Brain Natriuretic Peptide (BNPs) or NT-proBNP
  4.1.6 Ischemia-modified Albumin (IMA)
  4.1.7 Others
4.2 By Type - Global Cardiac Biomarkers Testing Revenue & Forecasts
  4.2.1 By Type - Global Cardiac Biomarkers Testing Revenue, 2017-2022
  4.2.2 By Type - Global Cardiac Biomarkers Testing Revenue, 2023-2028
  4.2.3 By Type - Global Cardiac Biomarkers Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cardiac Biomarkers Testing Market Size, 2021 & 2028
  5.1.2 Myocardial Infarction
  5.1.3 Congestive Heart Failure
  5.1.4 Acute Coronary Syndrome
  5.1.5 Atherosclerosis
  5.1.6 Others
5.2 By Application - Global Cardiac Biomarkers Testing Revenue & Forecasts
  5.2.1 By Application - Global Cardiac Biomarkers Testing Revenue, 2017-2022
  5.2.2 By Application - Global Cardiac Biomarkers Testing Revenue, 2023-2028
  5.2.3 By Application - Global Cardiac Biomarkers Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cardiac Biomarkers Testing Market Size, 2021 & 2028
6.2 By Region - Global Cardiac Biomarkers Testing Revenue & Forecasts
  6.2.1 By Region - Global Cardiac Biomarkers Testing Revenue, 2017-2022
  6.2.2 By Region - Global Cardiac Biomarkers Testing Revenue, 2023-2028
  6.2.3 By Region - Global Cardiac Biomarkers Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cardiac Biomarkers Testing Revenue, 2017-2028
  6.3.2 US Cardiac Biomarkers Testing Market Size, 2017-2028
  6.3.3 Canada Cardiac Biomarkers Testing Market Size, 2017-2028
  6.3.4 Mexico Cardiac Biomarkers Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cardiac Biomarkers Testing Revenue, 2017-2028
  6.4.2 Germany Cardiac Biomarkers Testing Market Size, 2017-2028
  6.4.3 France Cardiac Biomarkers Testing Market Size, 2017-2028
  6.4.4 U.K. Cardiac Biomarkers Testing Market Size, 2017-2028
  6.4.5 Italy Cardiac Biomarkers Testing Market Size, 2017-2028
  6.4.6 Russia Cardiac Biomarkers Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Cardiac Biomarkers Testing Market Size, 2017-2028
  6.4.8 Benelux Cardiac Biomarkers Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cardiac Biomarkers Testing Revenue, 2017-2028
  6.5.2 China Cardiac Biomarkers Testing Market Size, 2017-2028
  6.5.3 Japan Cardiac Biomarkers Testing Market Size, 2017-2028
  6.5.4 South Korea Cardiac Biomarkers Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Cardiac Biomarkers Testing Market Size, 2017-2028
  6.5.6 India Cardiac Biomarkers Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cardiac Biomarkers Testing Revenue, 2017-2028
  6.6.2 Brazil Cardiac Biomarkers Testing Market Size, 2017-2028
  6.6.3 Argentina Cardiac Biomarkers Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cardiac Biomarkers Testing Revenue, 2017-2028
  6.7.2 Turkey Cardiac Biomarkers Testing Market Size, 2017-2028
  6.7.3 Israel Cardiac Biomarkers Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Cardiac Biomarkers Testing Market Size, 2017-2028
  6.7.5 UAE Cardiac Biomarkers Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Cardiac Biomarkers Testing Major Product Offerings
  7.1.4 Abbott Laboratories Cardiac Biomarkers Testing Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Becton, Dickinson and Company
  7.2.1 Becton, Dickinson and Company Corporate Summary
  7.2.2 Becton, Dickinson and Company Business Overview
  7.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Major Product Offerings
  7.2.4 Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue in Global Market (2017-2022)
  7.2.5 Becton, Dickinson and Company Key News
7.3 BioMerieux
  7.3.1 BioMerieux Corporate Summary
  7.3.2 BioMerieux Business Overview
  7.3.3 BioMerieux Cardiac Biomarkers Testing Major Product Offerings
  7.3.4 BioMerieux Cardiac Biomarkers Testing Revenue in Global Market (2017-2022)
  7.3.5 BioMerieux Key News
7.4 Bio-Rad Laboratories, Inc.
  7.4.1 Bio-Rad Laboratories, Inc. Corporate Summary
  7.4.2 Bio-Rad Laboratories, Inc. Business Overview
  7.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Major Product Offerings
  7.4.4 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue in Global Market (2017-2022)
  7.4.5 Bio-Rad Laboratories, Inc. Key News
7.5 Danaher Corporation
  7.5.1 Danaher Corporation Corporate Summary
  7.5.2 Danaher Corporation Business Overview
  7.5.3 Danaher Corporation Cardiac Biomarkers Testing Major Product Offerings
  7.5.4 Danaher Corporation Cardiac Biomarkers Testing Revenue in Global Market (2017-2022)
  7.5.5 Danaher Corporation Key News
7.6 ROCHE
  7.6.1 ROCHE Corporate Summary
  7.6.2 ROCHE Business Overview
  7.6.3 ROCHE Cardiac Biomarkers Testing Major Product Offerings
  7.6.4 ROCHE Cardiac Biomarkers Testing Revenue in Global Market (2017-2022)
  7.6.5 ROCHE Key News
7.7 Siemens AG
  7.7.1 Siemens AG Corporate Summary
  7.7.2 Siemens AG Business Overview
  7.7.3 Siemens AG Cardiac Biomarkers Testing Major Product Offerings
  7.7.4 Siemens AG Cardiac Biomarkers Testing Revenue in Global Market (2017-2022)
  7.7.5 Siemens AG Key News
7.8 Thermo Fisher Scientific, Inc.
  7.8.1 Thermo Fisher Scientific, Inc. Corporate Summary
  7.8.2 Thermo Fisher Scientific, Inc. Business Overview
  7.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Major Product Offerings
  7.8.4 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue in Global Market (2017-2022)
  7.8.5 Thermo Fisher Scientific, Inc. Key News
7.9 PerkinElmer Inc.
  7.9.1 PerkinElmer Inc. Corporate Summary
  7.9.2 PerkinElmer Inc. Business Overview
  7.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Major Product Offerings
  7.9.4 PerkinElmer Inc. Cardiac Biomarkers Testing Revenue in Global Market (2017-2022)
  7.9.5 PerkinElmer Inc. Key News
7.10 Tosoh Corporation
  7.10.1 Tosoh Corporation Corporate Summary
  7.10.2 Tosoh Corporation Business Overview
  7.10.3 Tosoh Corporation Cardiac Biomarkers Testing Major Product Offerings
  7.10.4 Tosoh Corporation Cardiac Biomarkers Testing Revenue in Global Market (2017-2022)
  7.10.5 Tosoh Corporation Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Cardiac Biomarkers Testing Market Opportunities & Trends in Global Market
Table 2. Cardiac Biomarkers Testing Market Drivers in Global Market
Table 3. Cardiac Biomarkers Testing Market Restraints in Global Market
Table 4. Key Players of Cardiac Biomarkers Testing in Global Market
Table 5. Top Cardiac Biomarkers Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cardiac Biomarkers Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cardiac Biomarkers Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cardiac Biomarkers Testing Product Type
Table 9. List of Global Tier 1 Cardiac Biomarkers Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cardiac Biomarkers Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cardiac Biomarkers Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cardiac Biomarkers Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cardiac Biomarkers Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cardiac Biomarkers Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cardiac Biomarkers Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cardiac Biomarkers Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cardiac Biomarkers Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cardiac Biomarkers Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cardiac Biomarkers Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cardiac Biomarkers Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cardiac Biomarkers Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cardiac Biomarkers Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cardiac Biomarkers Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cardiac Biomarkers Testing Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Cardiac Biomarkers Testing Product Offerings
Table 32. Abbott Laboratories Cardiac Biomarkers Testing Revenue (US$, Mn), (2017-2022)
Table 33. Becton, Dickinson and Company Corporate Summary
Table 34. Becton, Dickinson and Company Cardiac Biomarkers Testing Product Offerings
Table 35. Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue (US$, Mn), (2017-2022)
Table 36. BioMerieux Corporate Summary
Table 37. BioMerieux Cardiac Biomarkers Testing Product Offerings
Table 38. BioMerieux Cardiac Biomarkers Testing Revenue (US$, Mn), (2017-2022)
Table 39. Bio-Rad Laboratories, Inc. Corporate Summary
Table 40. Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Product Offerings
Table 41. Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue (US$, Mn), (2017-2022)
Table 42. Danaher Corporation Corporate Summary
Table 43. Danaher Corporation Cardiac Biomarkers Testing Product Offerings
Table 44. Danaher Corporation Cardiac Biomarkers Testing Revenue (US$, Mn), (2017-2022)
Table 45. ROCHE Corporate Summary
Table 46. ROCHE Cardiac Biomarkers Testing Product Offerings
Table 47. ROCHE Cardiac Biomarkers Testing Revenue (US$, Mn), (2017-2022)
Table 48. Siemens AG Corporate Summary
Table 49. Siemens AG Cardiac Biomarkers Testing Product Offerings
Table 50. Siemens AG Cardiac Biomarkers Testing Revenue (US$, Mn), (2017-2022)
Table 51. Thermo Fisher Scientific, Inc. Corporate Summary
Table 52. Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Product Offerings
Table 53. Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue (US$, Mn), (2017-2022)
Table 54. PerkinElmer Inc. Corporate Summary
Table 55. PerkinElmer Inc. Cardiac Biomarkers Testing Product Offerings
Table 56. PerkinElmer Inc. Cardiac Biomarkers Testing Revenue (US$, Mn), (2017-2022)
Table 57. Tosoh Corporation Corporate Summary
Table 58. Tosoh Corporation Cardiac Biomarkers Testing Product Offerings
Table 59. Tosoh Corporation Cardiac Biomarkers Testing Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Cardiac Biomarkers Testing Segment by Type in 2021
Figure 2. Cardiac Biomarkers Testing Segment by Application in 2021
Figure 3. Global Cardiac Biomarkers Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cardiac Biomarkers Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cardiac Biomarkers Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cardiac Biomarkers Testing Revenue in 2021
Figure 8. By Type - Global Cardiac Biomarkers Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cardiac Biomarkers Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cardiac Biomarkers Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cardiac Biomarkers Testing Revenue Market Share, 2017-2028
Figure 12. US Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cardiac Biomarkers Testing Revenue Market Share, 2017-2028
Figure 16. Germany Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cardiac Biomarkers Testing Revenue Market Share, 2017-2028
Figure 24. China Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cardiac Biomarkers Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cardiac Biomarkers Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cardiac Biomarkers Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BioMerieux Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Danaher Corporation Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. ROCHE Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Siemens AG Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. PerkinElmer Inc. Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Tosoh Corporation Cardiac Biomarkers Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications